WT1 Is an Integral Component of an Antibody Panel to Distinguish Pancreaticobiliary and Some Ovarian Epithelial Neoplasms
Open Access
- 1 August 2001
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 116 (2) , 246-252
- https://doi.org/10.1309/8x4t-35b7-7529-qe7x
Abstract
We investigated whether a panel of antibodies including WT1 could separate pancreaticobiliary and ovarian carcinomas by staining 64 pancreaticobiliarKeywords
This publication has 25 references indexed in Scilit:
- Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 CasesLaboratory Investigation, 2000
- Genetic Alterations of the WT1 Gene in Papillary Serous Carcinoma of the PeritoneumGynecologic Oncology, 2000
- Evaluation of Diagnostic Criteria and Behavior of Ovarian Intestinal-Type Mucinous TumorsThe American Journal of Surgical Pathology, 1999
- Cytokeratin Profile of Extrahepatic Pancreaticobiliary Epithelia and Their CarcinomasApplied Immunohistochemistry & Molecular Morphology, 1997
- Molecular mechanisms possibly affecting WT1 function in human ovarian tumorsInternational Journal of Cancer, 1994
- Association of Mucinous Tumors of the Ovary and AppendixThe American Journal of Surgical Pathology, 1993
- Analysis of the 11p13 Wilms' Tumor Suppressor Gene (WTI) in Ovarian TumorsCancer Investigation, 1993
- Expression of the Wilms' tumor gene WT1 in the murine urogenital system.Genes & Development, 1991
- Serous Papillary Carcinomas Arising from the Peritoneum and Ovaries. A Clinicopathologic and Immunohistochemical ComparisonInternational Journal of Gynecological Pathology, 1989
- The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cellsPublished by Elsevier ,1982